C C Patrick1. 1. Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Christian.Patrick@STJUDE.ORG
Abstract
BACKGROUND: The use of fluorinated quinolone antibiotics to selectively decontaminate the gastrointestinal tract is a reasonable alternative to prevent infection in neutropenic patients. The fluoroquinolones represent ideal antibiotics with which to achieve the principles of selective decontamination by allowing colonization of anaerobes to inhibit the adherence, colonization and proliferation of potentially pathogenic aerobic flora. OBJECTIVE: This report describes the prophylactic use of fluoroquinolones in neutropenic patients. RESULTS: The majority of studies of fluoroquinolone prophylaxis in neutropenic patients have shown a reduction in documented Gram-negative bacterial infections. However, Gram-positive infections, particularly those with viridans streptococci, present a major impediment to the use of single agent prophylaxis with a quinolone. CONCLUSION: Prophylaxis with fluoroquinolones in neutropenic patients was found to be advantageous, but it must be balanced against the risk of Gram-positive infections and the potential for antibiotic resistance.
BACKGROUND: The use of fluorinated quinolone antibiotics to selectively decontaminate the gastrointestinal tract is a reasonable alternative to prevent infection in neutropenicpatients. The fluoroquinolones represent ideal antibiotics with which to achieve the principles of selective decontamination by allowing colonization of anaerobes to inhibit the adherence, colonization and proliferation of potentially pathogenic aerobic flora. OBJECTIVE: This report describes the prophylactic use of fluoroquinolones in neutropenicpatients. RESULTS: The majority of studies of fluoroquinolone prophylaxis in neutropenicpatients have shown a reduction in documented Gram-negative bacterial infections. However, Gram-positive infections, particularly those with viridans streptococci, present a major impediment to the use of single agent prophylaxis with a quinolone. CONCLUSION: Prophylaxis with fluoroquinolones in neutropenicpatients was found to be advantageous, but it must be balanced against the risk of Gram-positive infections and the potential for antibiotic resistance.
Authors: Dipenkumar Modi; Hyejeong Jang; Seongho Kim; Malini Surapaneni; Kamya Sankar; Abhinav Deol; Lois Ayash; Divaya Bhutani; Lawrence G Lum; Voravit Ratanatharathorn; Richard Manasa; Kendra Mellert; Pranatharthi Chandrasekar; Joseph P Uberti Journal: Support Care Cancer Date: 2017-04-02 Impact factor: 3.603
Authors: Lisa M McGregor; Clinton F Stewart; Kristine R Crews; Michael Tagen; Amy Wozniak; Jianrong Wu; M Beth McCarville; Fariba Navid; Victor M Santana; Peter J Houghton; Wayne L Furman; Carlos Rodriguez-Galindo Journal: Pediatr Blood Cancer Date: 2011-04-20 Impact factor: 3.167
Authors: Anat Gafter-Gvili; Abigail Fraser; Mical Paul; Liat Vidal; Theresa A Lawrie; Marianne D van de Wetering; Leontien C M Kremer; Leonard Leibovici Journal: Cochrane Database Syst Rev Date: 2012-01-18
Authors: Dong Gun Lee; Su Mi Choi; Jung Hyun Choi; Jin Hong Yoo; Yoon Hee Park; Yoo Jin Kim; Seok Lee; Chang Ki Min; Hee Je Kim; Dong Wook Kim; Jong Wook Lee; Woo Sung Min; Wan Shik Shin; Chun Choo Kim Journal: Korean J Intern Med Date: 2002-03 Impact factor: 2.884